Brief: Carmat Reports Q1 2025 Sales Of EUR 2.4 Mln
09/04/2025 16:49
April 9 (Reuters) - Carmat SA ALCAR.PA: DELIVERS Q1 2025 RESULTS IN LINE WITH ITS OBJECTIVES QUARTERLY SALES OF EUR 2.4M RECRUITMENT 94% COMPLETE FOR EFICAS CLINICAL TRIAL CASH RUNWAY EXTENDS TO END OF MAY 2025 ANTICIPATES BEING IN POSITION TO MAKE ENHANCED VERSION OF ITS ARTIFICIAL HEART AVAILABLE TO HEALTHCARE PROFESSIONALS BY END-2025 Source text: ID:nBwsbfFda Further company coverage: ALCAR.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Carmat SA
See all newsBrief: Carmat Receives Takeover Bid
Brief: Carmat SAS Submits Bid For Carmat SA Within Ongoing Receivership Procedure
Brief: Carmat Says Liquidation Review Postponed Until Nov 25
Brief: Carmat: Judiciary Administrator Has Submitted Request To Convert Receivership Into Liquidation To Court
Carmat says imminent liquidation now 'extremely probable'